TNF and rheumatoid arthritis: The serum levels of miR-16-5p, miR-23-3p, miR125b-5p, miR-126-3p, miRN-146α-5p, and miR-223-3p in RA patients were identified as potential novel biomarkers for predicting and monitoring therapy outcomes to anti-TNFα/DMARD combination therapies [66].